Novartis loses against Dongkook Pharmaceutical over hyperpituitarism patent

Published: 2016-03-08 15:40:03

Updated: 2016-03-08 15:40:03

Novartis lost on a trail for injunction against infringement of the hyperpituitarism patent against Dongkook Pharmaceutical.

The 11^th Civil Affairs Division, Seoul Central District Court, dismissed the request for injunction against infringement filed by Novartis against Dongkook Pharmaceutical.

Novartis has owned the patent right under the invention name called ‘Release-type Drug Containin...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.